Alejandro Murguia-Campos

Mexico City, DIF 14080, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Reply to: "Liver fibrosis and adverse outcomes in COVID-19".

Nutritional therapy for hepatocellular carcinoma.

Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19.

Showing 1-12 of 20

Last Updated: 09/26/2026